News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
873,032 Results
Type
Article (88166)
Company Profile (825)
Press Release (784021)
Multimedia
Podcasts (206)
Webinars (30)
Section
Business (233344)
Career Advice (4152)
Deals (39895)
Drug Delivery (155)
Drug Development (91473)
Employer Resources (205)
FDA (18431)
Job Trends (17439)
News (398112)
Policy (39994)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3023)
Academic (2)
Accelerated approval (40)
Adcomms (36)
Allergies (161)
Alliances (56982)
ALS (190)
Alzheimer's disease (1825)
Antibody-drug conjugate (ADC) (375)
Approvals (18629)
Artificial intelligence (676)
Autoimmune disease (189)
Automation (47)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (212)
Biotechnology (490)
Bladder cancer (175)
Brain cancer (69)
Breast cancer (693)
Cancer (5310)
Cardiovascular disease (469)
Career advice (3578)
Career pathing (43)
CAR-T (317)
CDC (67)
Celiac Disease (2)
Cell therapy (870)
Cervical cancer (39)
Clinical research (77362)
Collaboration (1938)
Company closure (5)
Compensation (1222)
Complete response letters (79)
COVID-19 (3003)
CRISPR (107)
C-suite (956)
Cystic fibrosis (155)
Data (6633)
Decentralized trials (2)
Denatured (76)
Depression (160)
Diabetes (553)
Diagnostics (7317)
Digital health (54)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (328)
Drug pricing (230)
Drug shortages (36)
Duchenne muscular dystrophy (258)
Earnings (100697)
Editorial (69)
Employer branding (25)
Employer resources (174)
Events (135764)
Executive appointments (1068)
FDA (21783)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (12)
Frontotemporal dementia (25)
Funding (1632)
Gene editing (230)
Generative AI (71)
Gene therapy (712)
GLP-1 (1164)
Government (5479)
Grass and pollen (8)
Guidances (389)
Healthcare (20978)
HIV (76)
Huntington's disease (53)
IgA nephropathy (89)
Immunology and inflammation (308)
Immuno-oncology (75)
Indications (128)
Infectious disease (3320)
Inflammatory bowel disease (218)
Inflation Reduction Act (17)
Influenza (134)
Intellectual property (268)
Interviews (817)
IPO (17970)
IRA (61)
Job creations (5202)
Job search strategy (2867)
JPM (73)
Kidney cancer (20)
Labor market (98)
Layoffs (662)
Leadership (44)
Legal (10166)
Liver cancer (100)
Longevity (19)
Lung cancer (714)
Lymphoma (395)
Machine learning (48)
Management (66)
Manufacturing (916)
MASH (182)
Medical device (15086)
Medtech (15150)
Mergers & acquisitions (23033)
Metabolic disorders (1470)
mRNA (201)
Multiple sclerosis (176)
NASH (23)
Neurodegenerative disease (382)
Neuropsychiatric disorders (108)
Neuroscience (3237)
Neurotech (1)
NextGen: Class of 2026 (7710)
Non-profit (5121)
Now hiring (70)
Obesity (717)
Opinion (347)
Ovarian cancer (174)
Pain (226)
Pancreatic cancer (250)
Parkinson's disease (317)
Partnered (39)
Patents (545)
Patient recruitment (545)
Peanut (64)
People (67134)
Pharmaceutical (145)
Pharmacy benefit managers (34)
Phase 1 (23905)
Phase 2 (33569)
Phase 3 (25289)
Pipeline (5971)
Policy (357)
Postmarket research (3554)
Preclinical (10721)
Press Release (72)
Prostate cancer (271)
Psychedelics (60)
Radiopharmaceuticals (317)
Rare diseases (999)
Real estate (7445)
Recruiting (81)
Regulatory (29319)
Reports (69)
Research institute (2742)
Resumes & cover letters (653)
Rett syndrome (30)
RNA editing (21)
RSV (90)
Schizophrenia (165)
Series A (274)
Series B (206)
Service/supplier (30)
Sickle cell disease (110)
Special edition (29)
Spinal muscular atrophy (179)
Sponsored (49)
Startups (4339)
State (2)
Stomach cancer (21)
Supply chain (117)
Tariffs (101)
The Weekly (128)
Vaccines (1190)
Venture capital (101)
Weight loss (493)
Women's health (104)
Worklife (23)
Date
Today (31)
Last 7 days (934)
Last 30 days (2907)
Last 365 days (32665)
2026 (5345)
2025 (33228)
2024 (38141)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (95)
Alaska (7)
Arizona (354)
Arkansas (15)
Asia (51678)
Australia (9081)
California (12140)
Canada (3459)
China (1223)
Colorado (512)
Connecticut (526)
Delaware (361)
Europe (118894)
Florida (1803)
Georgia (393)
Hawaii (4)
Idaho (68)
Illinois (1009)
India (80)
Indiana (573)
Iowa (24)
Japan (462)
Kansas (135)
Kentucky (47)
Louisiana (32)
Maine (84)
Maryland (1509)
Massachusetts (8893)
Michigan (379)
Minnesota (684)
Mississippi (7)
Missouri (144)
Montana (36)
Nebraska (30)
Nevada (132)
New Hampshire (88)
New Jersey (3260)
New Mexico (33)
New York (3202)
North Carolina (1675)
North Dakota (10)
Northern California (5868)
Ohio (375)
Oklahoma (23)
Oregon (55)
Pennsylvania (2417)
Puerto Rico (25)
Rhode Island (52)
South America (1665)
South Carolina (70)
South Dakota (1)
Southern California (4701)
Tennessee (185)
Texas (1909)
United States (43667)
Utah (368)
Vermont (1)
Virginia (306)
Washington D.C. (88)
Washington State (1008)
West Virginia (4)
Wisconsin (138)
Wyoming (2)
There are 873,032 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
KEYTRUDA® (pembrolizumab) Plus Paclitaxel With or Without Bevacizumab Significantly Improved Key Secondary Endpoint of Overall Survival (OS) Versus Paclitaxel With or Without Bevacizumab in Patients With Platinum-Resistant Recurrent Ovarian Cancer
March 2, 2026
·
19 min read
Press Releases
Signatera™ MRD Data at ASCO GU Highlights Potential Utility Across GU Cancers, Including for Bladder Preservation
March 2, 2026
·
7 min read
Press Releases
ORYZON Reports Financial Results and Corporate Update for Quarter Ended December 31st, 2025
March 2, 2026
·
20 min read
Press Releases
PADCEV™ + Keytruda® Cuts Risk of Recurrence or Death by Nearly 50% in Cisplatin-Eligible Muscle-Invasive Bladder Cancer
March 2, 2026
·
19 min read
Press Releases
KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) Reduced Risk of Event-Free Survival Events by 47% and Risk of Death by 35% for Cisplatin-Eligible Patients with Muscle-Invasive Bladder Cancer When Given Before and After Surgery
March 2, 2026
·
19 min read
Press Releases
The Michael J. Fox Foundation for Parkinson’s Research Appoints Richard Fitzgerald and Samir Kaul to Board of Directors
March 1, 2026
·
3 min read
Press Releases
Disclosure of a transparency notification from AOC Pharma S.à r.l.
March 1, 2026
·
2 min read
Press Releases
Four Feinstein Institutes Scientists Honored as National Academy of Inventors Senior Members
March 1, 2026
·
4 min read
Press Releases
Sarepta Therapeutics Announces Call for Applications for the 9th Annual Route 79, The Duchenne Scholarship Program
March 1, 2026
·
4 min read
Press Releases
Medsynaptic to Showcase Medsynapse PACS and Orthopedic Imaging Solutions at AAOS 2026 in New Orleans
March 1, 2026
·
3 min read
1 of 87,304
Next
